# MicroPort CardioFlow to acquire CRM Cayman for $680 million

MicroPort Scientific Corporation announced that its subsidiary MicroPort CardioFlow will acquire CRM Cayman through a subsidiary-to-subsidiary merger, valuing CRM Cayman at $680 million. The integration is expected to complete in Q1 2026.

- Type: Acquisition
- Announced: 2025-09-30
- Where: Cayman Islands
- Value: $680.0M
- Status: announced
- Products: cardiovascular devices, drug delivery platforms, imaging platforms
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MicroPort Scientific Corporation](https://endata.com/companies/20849.md) (investor)
- [MicroPort CardioFlow](https://endata.com/companies/87511.md) (acquirer)
- [CRM Cayman](https://endata.com/companies/87512.md) (target)

## Sources

- [flcube.com](https://flcube.com/microport-announces-680-million-merger-with-crm-cayman-expanding-cardio%E2%80%91medical-footprint/), 2025-09-30: "Under the terms, MicroPort CardioFlow will acquire CRM Cayman through a subsidiary‑to‑subsidiary merger, valuing the Cayman‑based entity at USD 680 million in pre‑transaction equity."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.